AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Biomechanical Study of the Lumbar Intervertebral Disc by Lever Positioning Manipulation

RecruitingNAAges 20 Years - 60 YearsAllThe Third Affiliated hospital of Zhejiang Chineseโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Purpose of Study: The purpose of this clinical trial is the clinical efficacy of different trigger modes of lever positioning manipulation (LPM) for the treatment of lumbar disc herniation (LDH). At the same time, the investigators considered from the perspective of virtual simulation and applied 3D finite element technology combined with dynamic capture system and mechanical sensing system to comprehensively evaluate the characteristics of biomechanical effects of different triggering modes of LPM on LDH. The main questions ansthe investigatorsred are: (1) To clarify what is the clinical effect of LPM in treating lumbar disc herniation?(2) Summarize the spatial motion laws and mechanical characteristics of the two triggering modes of LPM. Analyze the correlation betthe investigatorsen the LPM operation characteristics and the individual characteristics of LDH patients as the investig

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Healthy volunteers: 1. Healthy subjects with no history of lumbar spine disease, aged 20 to 60. 2. No obvious lumbar spine pain or previous diagnosis of lumbar spine-related disease. 3. Willing to participate in the study and have signed an informed consent form. Patients: 1. Aged 20 to 60 years. 2. Diagnosed with L4-L5 lumbar disc herniation by CT or MRI. 3. Stable vital signs, no serious systemic diseases, and no complications. 4. Willing to accept manipulation as a test subject. Exclusion Criteria: 1. Lumbar vertebrae fracture or dislocation. 2. Lumbar spine or lumbar soft tissue tumor, tuberculosis. 3. Lumbar spine fusion, paravertebral bone bridges, or severe osteoporosis. 4. History of lumbar spine surgery. 5. History of serious lumbar trauma. 6. Lumbar skin inflammation, skin breaks, or other skin conditions. 7. Serious primary diseases of the cardiac, hepatic, renal, or hematopoietic systems; psychiatric patients. 8. Extreme frailty or pregnancy. 9. Participation in other manipulative therapies that may interfere with the study. 10. Intolerable adverse reactions.
๐Ÿ’Š

What it tests

  • Lever positioning manipulation
  • Cluster of pseudo-manipulators
  • Mechanics and kinematics data acquisition of unilateral wrenching patterns in lever positioning manipulation
  • Mechanics and kinematics data acquisition of bilateral wrenching patterns in lever positioning manipulation
๐Ÿ“

Where

1 site
The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Hangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy